Tokyo, Japan

Tomohiro Chiba

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tomohiro Chiba

Introduction

Tomohiro Chiba is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of neurodegenerative disease research. With a focus on Alzheimer's disease, his work has led to the development of innovative methods and therapeutic agents.

Latest Patents

Chiba holds 2 patents that showcase his expertise. His first patent is a method for detecting candidate Alzheimer's disease drugs. This invention provides a method for detecting or diagnosing in vitro Alzheimer's disease, or memory and/or cognitive disorders, using a human biological sample and the inactivation of STAT3 protein as an indication. Additionally, it includes a method for screening therapeutic drugs for Alzheimer's disease or memory and/or cognitive disorders, utilizing the activation of STAT3 protein as an indication. His second patent relates to therapeutic agents of colivelin for neurodegenerative diseases. This invention involves a pharmaceutical composition for the treatment and/or prevention of neurodegenerative diseases, comprising specific polypeptides that inhibit neuronal cell death associated with these conditions.

Career Highlights

Throughout his career, Tomohiro Chiba has worked with various companies, including Kenzo Terashita. His innovative approach and dedication to research have positioned him as a key figure in the field of neurodegenerative disease treatment.

Collaborations

Chiba has collaborated with notable individuals such as Masaaki Matsuoka and Kenzo Terashita. These partnerships have further enhanced his research and development efforts.

Conclusion

Tomohiro Chiba's contributions to the field of neurodegenerative diseases through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches to Alzheimer's disease and related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…